Copyright Reports & Markets. All rights reserved.

Global Bromhexine Tablet Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Bromhexine Tablet Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 8mg
    • 1.3.3 Others
  • 1.4 Market Analysis by Manufacturing Method
    • 1.4.1 Overview: Global Bromhexine Tablet Consumption Value by Manufacturing Method: 2021 Versus 2025 Versus 2032
    • 1.4.2 Direct Compression
    • 1.4.3 Wet Granulation
  • 1.5 Market Analysis by Packaging
    • 1.5.1 Overview: Global Bromhexine Tablet Consumption Value by Packaging: 2021 Versus 2025 Versus 2032
    • 1.5.2 Aluminum Blister Packs
    • 1.5.3 Bottom Packs
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Bromhexine Tablet Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Chronic Bronchitis
    • 1.6.3 Asthma
    • 1.6.4 Other
  • 1.7 Global Bromhexine Tablet Market Size & Forecast
    • 1.7.1 Global Bromhexine Tablet Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Bromhexine Tablet Sales Quantity (2021-2032)
    • 1.7.3 Global Bromhexine Tablet Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sanofi (FR)
    • 2.1.1 Sanofi (FR) Details
    • 2.1.2 Sanofi (FR) Major Business
    • 2.1.3 Sanofi (FR) Bromhexine Tablet Product and Services
    • 2.1.4 Sanofi (FR) Bromhexine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sanofi (FR) Recent Developments/Updates
  • 2.2 Boehringer Ingelheim (DE)
    • 2.2.1 Boehringer Ingelheim (DE) Details
    • 2.2.2 Boehringer Ingelheim (DE) Major Business
    • 2.2.3 Boehringer Ingelheim (DE) Bromhexine Tablet Product and Services
    • 2.2.4 Boehringer Ingelheim (DE) Bromhexine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Boehringer Ingelheim (DE) Recent Developments/Updates
  • 2.3 Teva Pharmaceutical Industries (IL)
    • 2.3.1 Teva Pharmaceutical Industries (IL) Details
    • 2.3.2 Teva Pharmaceutical Industries (IL) Major Business
    • 2.3.3 Teva Pharmaceutical Industries (IL) Bromhexine Tablet Product and Services
    • 2.3.4 Teva Pharmaceutical Industries (IL) Bromhexine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Teva Pharmaceutical Industries (IL) Recent Developments/Updates
  • 2.4 Sandoz (CH)
    • 2.4.1 Sandoz (CH) Details
    • 2.4.2 Sandoz (CH) Major Business
    • 2.4.3 Sandoz (CH) Bromhexine Tablet Product and Services
    • 2.4.4 Sandoz (CH) Bromhexine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Sandoz (CH) Recent Developments/Updates
  • 2.5 Cipla (IN)
    • 2.5.1 Cipla (IN) Details
    • 2.5.2 Cipla (IN) Major Business
    • 2.5.3 Cipla (IN) Bromhexine Tablet Product and Services
    • 2.5.4 Cipla (IN) Bromhexine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Cipla (IN) Recent Developments/Updates
  • 2.6 Sun Pharmaceutical Industries (IN)
    • 2.6.1 Sun Pharmaceutical Industries (IN) Details
    • 2.6.2 Sun Pharmaceutical Industries (IN) Major Business
    • 2.6.3 Sun Pharmaceutical Industries (IN) Bromhexine Tablet Product and Services
    • 2.6.4 Sun Pharmaceutical Industries (IN) Bromhexine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sun Pharmaceutical Industries (IN) Recent Developments/Updates
  • 2.7 Wanbangde Pharmaceutical (CN)
    • 2.7.1 Wanbangde Pharmaceutical (CN) Details
    • 2.7.2 Wanbangde Pharmaceutical (CN) Major Business
    • 2.7.3 Wanbangde Pharmaceutical (CN) Bromhexine Tablet Product and Services
    • 2.7.4 Wanbangde Pharmaceutical (CN) Bromhexine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Wanbangde Pharmaceutical (CN) Recent Developments/Updates
  • 2.8 Hengshan Pharmaceutical (CN)
    • 2.8.1 Hengshan Pharmaceutical (CN) Details
    • 2.8.2 Hengshan Pharmaceutical (CN) Major Business
    • 2.8.3 Hengshan Pharmaceutical (CN) Bromhexine Tablet Product and Services
    • 2.8.4 Hengshan Pharmaceutical (CN) Bromhexine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Hengshan Pharmaceutical (CN) Recent Developments/Updates
  • 2.9 Diao Group (CN)
    • 2.9.1 Diao Group (CN) Details
    • 2.9.2 Diao Group (CN) Major Business
    • 2.9.3 Diao Group (CN) Bromhexine Tablet Product and Services
    • 2.9.4 Diao Group (CN) Bromhexine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Diao Group (CN) Recent Developments/Updates

3 Competitive Environment: Bromhexine Tablet by Manufacturer

  • 3.1 Global Bromhexine Tablet Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Bromhexine Tablet Revenue by Manufacturer (2021-2026)
  • 3.3 Global Bromhexine Tablet Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Bromhexine Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Bromhexine Tablet Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Bromhexine Tablet Manufacturer Market Share in 2025
  • 3.5 Bromhexine Tablet Market: Overall Company Footprint Analysis
    • 3.5.1 Bromhexine Tablet Market: Region Footprint
    • 3.5.2 Bromhexine Tablet Market: Company Product Type Footprint
    • 3.5.3 Bromhexine Tablet Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Bromhexine Tablet Market Size by Region
    • 4.1.1 Global Bromhexine Tablet Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Bromhexine Tablet Consumption Value by Region (2021-2032)
    • 4.1.3 Global Bromhexine Tablet Average Price by Region (2021-2032)
  • 4.2 North America Bromhexine Tablet Consumption Value (2021-2032)
  • 4.3 Europe Bromhexine Tablet Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Bromhexine Tablet Consumption Value (2021-2032)
  • 4.5 South America Bromhexine Tablet Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Bromhexine Tablet Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Bromhexine Tablet Sales Quantity by Type (2021-2032)
  • 5.2 Global Bromhexine Tablet Consumption Value by Type (2021-2032)
  • 5.3 Global Bromhexine Tablet Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Bromhexine Tablet Sales Quantity by Application (2021-2032)
  • 6.2 Global Bromhexine Tablet Consumption Value by Application (2021-2032)
  • 6.3 Global Bromhexine Tablet Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Bromhexine Tablet Sales Quantity by Type (2021-2032)
  • 7.2 North America Bromhexine Tablet Sales Quantity by Application (2021-2032)
  • 7.3 North America Bromhexine Tablet Market Size by Country
    • 7.3.1 North America Bromhexine Tablet Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Bromhexine Tablet Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Bromhexine Tablet Sales Quantity by Type (2021-2032)
  • 8.2 Europe Bromhexine Tablet Sales Quantity by Application (2021-2032)
  • 8.3 Europe Bromhexine Tablet Market Size by Country
    • 8.3.1 Europe Bromhexine Tablet Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Bromhexine Tablet Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Bromhexine Tablet Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Bromhexine Tablet Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Bromhexine Tablet Market Size by Region
    • 9.3.1 Asia-Pacific Bromhexine Tablet Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Bromhexine Tablet Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Bromhexine Tablet Sales Quantity by Type (2021-2032)
  • 10.2 South America Bromhexine Tablet Sales Quantity by Application (2021-2032)
  • 10.3 South America Bromhexine Tablet Market Size by Country
    • 10.3.1 South America Bromhexine Tablet Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Bromhexine Tablet Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Bromhexine Tablet Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Bromhexine Tablet Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Bromhexine Tablet Market Size by Country
    • 11.3.1 Middle East & Africa Bromhexine Tablet Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Bromhexine Tablet Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Bromhexine Tablet Market Drivers
  • 12.2 Bromhexine Tablet Market Restraints
  • 12.3 Bromhexine Tablet Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Bromhexine Tablet and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Bromhexine Tablet
  • 13.3 Bromhexine Tablet Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Bromhexine Tablet Typical Distributors
  • 14.3 Bromhexine Tablet Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Bromhexine Tablet market size was valued at US$ 371 million in 2025 and is forecast to a readjusted size of US$ 524 million by 2032 with a CAGR of 5.1% during review period.
    A Bromhexine Tablet is an oral, small-molecule mucolytic formulation prescribed primarily to alleviate respiratory distress associated with severe, productive coughs. Originally derived from the synthetic modification of vasicine—an alkaloid extracted from the medicinal plant Adhatoda vasica—bromhexine works directly within the respiratory tract to break down sticky bronchial secretions. By disrupting the complex structure of acid mucopolysaccharide fibers present in phlegm, the active medication drastically reduces mucus viscosity and increases total fluid volume. This thinning mechanism stimulates ciliary activity along the respiratory lining, rendering thick secretions much easier for the patient to expectorate through coughing. Routinely indicated for chronic bronchitis, emphysema, tracheobronchitis, and acute respiratory infections, these tablets improve overall alveolar ventilation, ease the mechanical strain of persistent coughing, and are frequently combined with antibiotics to enhance total drug penetration into deep pulmonary tissues.
    In 2025, global Bromhexine Tablet production reached approximately 31.78 million units, with an average global market price of around US$ 11.36 per unit. And global Bromhexine Tablet production capacity reached approximately 38 million units. The average gross margin in this industry reached 41.65%.
    The supply chain for bromhexine tablets relies heavily on multi-national active pharmaceutical ingredient (API) synthesis, strict compliance with international pharmacopeias, and specialized retail drug distribution. The upstream supply chain handles the chemical synthesis of raw materials and mass API manufacturing according to rigorous Current Good Manufacturing Practice (cGMP) standards. Surya Life Sciences Ltd. acts as a vital upstream supplier, producing bulk quantities of premium, medicinal-grade Bromhexine Hydrochloride (HCl) powder matching global IP, BP, and EP quality baselines. On the raw chemical and alternative distribution side, AMSA S.p.A. in Italy serves as a prominent European producer of high-purity bromhexine intermediates, while Fengchen Group Co., Ltd. operates as a massive upstream chemical supplier out of China, furnishing bulk active raw materials packaged in protective fiber drums for global pharmaceutical manufacturing complexes.
    Conversely, the downstream supply chain spans the commercial tablet manufacturing tier, specialized logistics networks, and end-user clinical facilities. Multinational pharmaceutical formulation brands, including Sanofi (which manufactures the widely recognized Bisolvon product line) and Cipla Ltd. (producers of the generic Bromex series), act as primary downstream customers, purchasing raw bulk APIs to execute automated powder blending, high-speed tablet compression, and blister-pack sealing. These finished pharmaceuticals are distributed through global supply channels to healthcare distributors and large-scale hospital buying networks. A major final downstream customer is the National Health Service (NHS) in the United Kingdom, alongside commercial global pharmacy networks like CVS Health Corporation, which acquire certified bromhexine tablets to restock clinical dispensaries, fulfill patient prescriptions, and manage public respiratory wellness.
    This report is a detailed and comprehensive analysis for global Bromhexine Tablet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Bromhexine Tablet market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Bromhexine Tablet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Bromhexine Tablet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Bromhexine Tablet market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Bromhexine Tablet
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Bromhexine Tablet market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi (FR), Boehringer Ingelheim (DE), Teva Pharmaceutical Industries (IL), Sandoz (CH), Cipla (IN), Sun Pharmaceutical Industries (IN), Wanbangde Pharmaceutical (CN), Hengshan Pharmaceutical (CN), Diao Group (CN), etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Bromhexine Tablet market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    8mg
    Others
    Market segment by Manufacturing Method
    Direct Compression
    Wet Granulation
    Market segment by Packaging
    Aluminum Blister Packs
    Bottom Packs
    Market segment by Application
    Chronic Bronchitis
    Asthma
    Other
    Major players covered
    Sanofi (FR)
    Boehringer Ingelheim (DE)
    Teva Pharmaceutical Industries (IL)
    Sandoz (CH)
    Cipla (IN)
    Sun Pharmaceutical Industries (IN)
    Wanbangde Pharmaceutical (CN)
    Hengshan Pharmaceutical (CN)
    Diao Group (CN)
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Bromhexine Tablet product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Bromhexine Tablet, with price, sales quantity, revenue, and global market share of Bromhexine Tablet from 2021 to 2026.
    Chapter 3, the Bromhexine Tablet competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Bromhexine Tablet breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Bromhexine Tablet market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Bromhexine Tablet.
    Chapter 14 and 15, to describe Bromhexine Tablet sales channel, distributors, customers, research findings and conclusion.

    Buy now